Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sugammadex Efficacy and Safety in Elderly vs Adult Subjects
NCT00474617Phase 3Completed
- Sponsor
- Merck & Co.
- Start
- Dec 2005
- Primary completion
- Oct 2006
- Modality
- Biodegradable Polymers, Small Molecules
01
Overview
A Phase 3 trial of Sugammadex in neuromuscular blockade (NMB), sponsored by Merck & Co.. Started Dec 2005; status: completed.
02
Drugs
Sugammadex
03
Conditions
neuromuscular blockade (NMB)
Beyond the preview
Go deeper on NCT00474617.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00474617.